BVT Knock-Out ALGN/ DE000VV924M5 /
2024-06-28 8:41:42 AM | Chg.0.00 | Bid9:20:34 AM | Ask9:20:34 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
8.76EUR | 0.00% | 8.77 Bid Size: 4,000 |
8.96 Ask Size: 4,000 |
Align Technology Inc | 149.79 USD | 2078-12-31 | Call |
GlobeNewswire
3:00 AM
OWENS & MINOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Owens & Minor, Inc. on Behalf of O...
GlobeNewswire
3:00 AM
BLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Long-Term St...
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
2:48 AM
LAKESIDE HOLDING LIMITED ANNOUNCES PRICING OF $6.75 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
2:22 AM
CFIUS Approval Obtained for the Planned Merger of North American Stainless, Inc. and Haynes Internat...
GlobeNewswire
2:00 AM
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
1:51 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39 AM
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:38 AM
Unlocking the Future of Trading with Spotrade.net: A Leader in AI Spot Signals
GlobeNewswire
1:31 AM
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30 AM
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17 AM
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10 AM
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
1:00 AM
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
12:30 AM
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
12:29 AM
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030